22nd International Symposium on Infections in the Critically Ill Patient

Start

Wed, 8 Feb 2017, 08:45

End

Fri, 10 Feb 2017, 01:00

WebSite

http://infections-online.com/

Venue:

KEYNOTE SPEAKERS

Prof. Antonio Artigas, MD, PhD

ICU Management & Practice Editorial Board Member

******@***cspt.es

Dept. of Intensive Care Medicine Hospital de Sabadell - CIBER de Enfermedades Respiratorias Corporació Sanitaria I Universitària Parc Taulí Sabadell, Spain

Prof. Michael Niederman, MD, MACP, FCCP, FCCM, FERS

******@***med.cornell.edu

Clinical Director, Pulmonary and Critical Care - New York Presbyterian-Weill Cornell Medical Center (2015-)
Professor of Clinical Medicine - Weill Cornell Medical College (2015-)

Prof Antoni Torres

******@***clinic.ub.es

Hospital Clinic

Prof Jean-Louis Vincent, MD, PhD

Editor-in-Chief, ICU Management & Practice

******@***icu-management.org

Professor - Department of Intensive Care Erasme Hospital Université libre de Bruxelles: Brussels, Belgium

Exhibit

Symposia

Workshops

Organiser

Sponsor

The aim of this two days symposium is to review current concepts, technology and present advances in infections in the critically ill patients. Sepsis, Pulmonary Infections, Basic Research, Pulmonary Infections Treatment and ProphylaxisTherapyofsevereinfections will bethetopicsof the main sessions presented by experts who will review and update the new advances on infections in the critically ill patient. At the end of each session a Clinical Controversy, Pannel Discussion or Case Report Discussion will be organized.

Posters

The posters should be sent before 18th December 2016 to this address: [email protected]

ORGANIZED BY

Antonio Artigas, MD
Critical Care Center, Sabadell Hospital, University Institute Parc Taulí, Autonomous
University of Barcelona, Ciberes, Spain

Jean Carlet, MD
Direction de l’Amélioration de la Qualité et de la Securité des Soins, Paris, France

Paulo Mergulhão, MD
Emergency and Intensive Care Medicine Department Centro Hospitalar Sao Joao Faculty of Medicine, University of Porto, Porto, Portugal

Michael Niederman, MD
Division of Pulmonary and Critical Care Medicine, New York Presbyterian Hospital, Weill Cornell Medical College, USA

José Arthur Paiva, MD
Emergency and Intensive Care Medicine Department Centro Hospitalar Sao Joao, Faculty of Medicine, University of Porto, Porto, Portugal

Antoni Torres, MD
Pulmonology Department, Clinic Hospital of Barcelona, Ciberes, Spain,

ENDORSED BY


	Prior to 31/12/2016	After 31/12/2016
*MEMBERS	250€	350€
NON MEMBERS	350€	450€

One day offer
	Prior to 31/12/2016	After 31/12/2016
*MEMBERS	85€	150€
NON MEMBERS	100€	180€

The following registration fees include access to the Scientific Sessions and the Commercial Exhibition, Conference documents, Certificate of Attendance and Coffee Breaks

* Members of:

- Ciberes

- ESA

- GSA

- ICHS

- ISF

- Separ

- SPDIMC

- SPD

- SRLF

** A letter signed by the institution responsible is required to get this fee..

To Register, Please fill the form (type or block capital letters) and mail it or fax it directly to the Symposium Technical Secretariat:

Diagonal 662-664.
08034 Barcelona, Spain
Tel. + 34 93 252 04 00
Fax +34 93 206 57 91
[email protected]

PDF Registration Form


Wednesday, February 8th, 2017

08:45	Introduction
	A.Artigas, MD (Sabadell, Spain)
	J.Carlet, MD (Paris, France)
	P.Mergulhão, MD (Porto, Portugal)
	M.Niederman, MD (New York, USA)
	JA.Paiva, MD (Porto, Portugal)

I. SEPSIS

09:00	Surviving Sepsis Campaign Guidelines 2016: What changed? -M.Levy, MD (Rhode Island, USA)
09:20	Outlook for Sepsis: Do We Have a Roadmap- T.Calandra, MD (Lausanne, Switzerland)
09:40	Post-ICU Sepsis: The OUTCOME Study- J.Gonçalves Pereira, MD (Lisboa, Portugal)
10:00	Big Data For Better Sepsis Management -H.Gerlach, MD (Berlin, Germany)
10:20	Discussion
10:30	Break (Exhibition Area). Poster Discussion

II. THE END OF EGDT?

11:00	Lactate Clearance: How Much Is a Marker Response?- M.Levy, MD (Rhode Island, USA)
11:20	Protocol vs Individualized Treatment- M.Cecconi, MD (London, UK)
11:40	What Do I in my ICU? -C.Martin, MD (Marseille, France)
12:00	Therapeutical Goals For 2017 and Beyond- JL.Vincent, MD (Brussels, Belgium)
12:20	Discussion
12:30	Debate: New Sepsis Definitions: Real Progress?
	Moderator: I.Martin Loeches, MD (Dublin, Ireland)
	Pro: JL.Vincent, MD (Brussels, Belgium)
	Con: R.Ferrer, MD (Barcelona, España)
13:00	Lunch

Symposium

VASCULAR TONE OR VOLUME STATUS?
Moderators: JL.Teboul, MD (Paris, France)
C.Martin, MD (Marseille, France)

14:00	Volume Status and Fluid Resuscitation: What is the solution? -M.Cecconi, MD (London, UK)
14:20	The SOSD Phases of Fluid Therapy- D.De Backer, MD (Brussels, Belgium)
14:40	Vassopressors in Sepsis: When to Start?- JL.Teboul, MD (Paris, France)
15:00	Discussion

III. DYSFUNCTION OF MICROCIRCULATION IN SEPSIS

15:30	Role Od Gut in Sepsis and MOF?- J. De Waele, MD (Gent, Belgium)
15:50	How to evaluate the Microcirculation?- C.Ince, MD (Amsterdam, The Netherlands)
16:10	How to Improve Microcirculation?- D.De Backer, MD (Brussels, Belgium)
16:30	Discussion
16:40	Break (Exhibition Area). Poster Discussion

Symposium

SEPSIS ASSOCIATED COAGULOPATHY
Moderators: A. Artigas, MD (Sabadell, Spain)
M.Schultz, MD (Amsterdam, The Netherlands)

17:10	Sepsis-Associated Coagulopathy: Still Common and
	Still Important- A. Artigas, MD (Sabadell, Spain)
17:30	Organ Dysfunction and Coagulation in Sepsis- M.Levi, MD (Amsterdam, The Netherlands)
17:50	Thrombomodulin In Sepsis: The SCARLET Study- JL.Vincent, MD (Brussels, Belgium)
18:10	Discussion

Thursday, February 9th, 2017

IV. NEW INSIGHTS IN THE PATHOGENESIS OF PNEUMONIA IN INTUBATED AND MECHANICAL VENTILATED PATIENTS

09:00	Changes in Microbiome During Mechanical Ventilation- LD Boss, MD (Amsterdam, Netherlands)
09:20	From Tracheobronchitis to VAP- S. Nseir, MD (Lille, France)
09:40	Selective Advantage of Multi-Drug Resistant Microbe During Prolonged Ventilation- I.Martin Loeches, MD (Dublin, Ireland)
10:00	Discussion
10:10	Break (Exhibition Area). Poster Discussion

V. MANAGEMENT OF PULMONARY INFECTIONS

10:40	Management of Severe Influenza Infections- MS.Niederman, MD (New York, USA)
11:00	Virus as a Cause of VAP- F.Froes, MD (Lisboa, Portugal)
11:20	Tracheostomy Practices: Are Risk Factors for VAP?- M.Antonelli, MD (Rome, Italy)
11:40	Ventilatory Support and VAP Prevention in Auster Seetings, Also Applicable in Your Unit? -M.Schultz, MD (Amsterdam, The Netherlands)
12:00	Novel Approaches to Treat Pulmonary Infections- T.Welte, MD (Hannover, Germany)
12:20	Discussion
12:20	Lunch

Symposium

CONTROVERSIES AND ADVANCES IN THE MANAGEMENT OF VAP
Moderators: I.Martin Loeches, MD (Dublin, Ireland)
JM Pereira, MD (Porto, Portugal)

13:30	Can Antiinflammatory Therapy Help Improve Outcome in VAP?- A.Torres, MD (Barcelona, Spain)
13:50	Are New Antibiotics Going To Help Us Manage VAP in the ICU?- MS.Niederman, MD (New York, USA)
14:10	Can Biomarkers Help With Antibiotic Stewardship?- J.Chastre, MD (Paris, France)
14:30	Discussion

VI. POINT-OF-CARE APPROACH TO INFECTIONS IN THE ICU

14:40	Early MIcrobiological Diagnostics on the ICU. Is it Possible?- E.Bouza, MD (Madrid, Spain)
15:00	Virus Diagnosis Is Important in the ICU?- J.Chastre, MD (Paris, France)
15:20	Biomarkers In AKI
15:40	Sepsis Biomarkers: An Overview- JL.Vincent, MD (Brussels, Belgium)
16:00	Discussion
16:10	Break (Exhibition area). Poster Discussion

VII. FROM THE PHYSIOPATHOLOGY TO THE BEDSIDE: THE IMMUNE RESPONSE

16:40	Sepsis: Ressistance vs Tolerance. Change of Paradigm- L.Moita, MD (Lisboa, Portugal)
17:00	Immunosupression in Sepsis: Is it important?- D.Payen, MD (Paris, France)
17:20	Semi-Selective Immune Modulation Using Hemoabsorption
17:40	Polimixin B Hemoperfusion: The EUPHRATES Study- M.Antonelli, MD (Rome, Italy)
18:00	Discussion

Friday, February 10th, 2017

VIII. NEW INSIGHTS OF ANTIBIOTIC THERAPY

09:00	New Antibiotics for the Treatment of Severe Infections -T.Calandra, MD (Lausanne, Switzerland)
09:20	Can We Reduce Antibiotic Resistance?- J.Carlet, MD (Paris, France)
09:40	Combination of Betalactam: When and Why?- JM Pereira, MD (Porto, Portugal)
10:00	Antibiotic in Extracorporeal Techniques -J.Gonçalves Pereira, MD (Lisboa, Portugal)
10:20	Continuous or Prolonged Infussion of Antibiotics- J.De Waele, MD (Gent, Belgium)
10:50	Discussion
11:00	Break (Exhibition Area). Poster Discussion

IX. WHAT IS NEW IN FUNGAL INFECTIONS

11:30	Prophylaxis and Prevention Therapy for Fungal Infections- T.Calandra, MD (Lausanne, Switzerland)
11:50	D-Escalation Therapy in Patients With Invasive Candidiasis- J.Garnacho-Montero, MD (Sevilla, Spain)
12:10	How Could We Reduce Antifungal Use? The STAFE Study-S.Nseir, MD (Lille, France)
12:30	Fungemia: What Is New? -JA.Paiva, MD (Porto, Portugal)
12:50	Discussion
13:00	Closing Remarks

Postgraduate Courses

NUTRITION THERAPY: State of the Art
ANTIBIOTIC THERAPY